ABI
JNJ icon

Adamant Biomedical Investments’s Johnson & Johnson JNJ Stock Holding History

Adamant Biomedical Investments’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4.18M Sell
40,000
-5,000
-11% -$527K 1% 37
2014
Q3 		$4.8M Buy
+45,000
New +$4.67M 1.2% 30

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Adamant Biomedical Investments's JNJ Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Johnson & Johnson (JNJ) stake by 11% in Q4 2014, selling an estimated $527K and leaving 40,000 shares worth $4.18M. The position accounts for 1% of the portfolio, ranked #37.

Adamant Biomedical Investments first reported a position in JNJ in Q3 2014 and has held it in 2 quarters since. The position peaked at $4.8M in Q3 2014. 2,121 funds tracked by Wall St. Rank hold JNJ as of Q4 2014.

  • Adamant Biomedical Investments held 40,000 shares of Johnson & Johnson worth $4.18M as of Q4 2014.
  • Adamant Biomedical Investments sold 5,000 Johnson & Johnson shares in Q4 2014, an estimated $527K.
  • Johnson & Johnson made up 1% of Adamant Biomedical Investments's portfolio in Q4 2014, its #37 holding.
  • Adamant Biomedical Investments first reported a position in Johnson & Johnson in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Johnson & Johnson position peaked at $4.8M in Q3 2014.
  • 2,121 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.